Univec Inc Stock Net Income

UNVC Stock  USD 0  0.0003  10.34%   
As of the 17th of February 2026, Univec has the Semi Deviation of 6.77, risk adjusted performance of 0.0371, and Coefficient Of Variation of 2879.87. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Univec Inc, as well as the relationship between them.
Univec's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Univec's valuation are provided below:
Univec Inc does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Please note, there is a significant difference between Univec's value and its price as these two are different measures arrived at by different means. Investors typically determine if Univec is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Univec's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Univec 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Univec's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Univec.
0.00
11/19/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/17/2026
0.00
If you would invest  0.00  in Univec on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Univec Inc or generate 0.0% return on investment in Univec over 90 days. Univec is related to or competes with Crescita Therapeutics. Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and intern... More

Univec Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Univec's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Univec Inc upside and downside potential and time the market with a certain degree of confidence.

Univec Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Univec's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Univec's standard deviation. In reality, there are many statistical measures that can use Univec historical prices to predict the future Univec's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Univec's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.0008.31
Details
Intrinsic
Valuation
LowRealHigh
0.0008.31
Details

Univec February 17, 2026 Technical Indicators

Univec Inc Backtested Returns

Univec appears to be out of control, given 3 months investment horizon. Univec Inc owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0833, which indicates the firm had a 0.0833 % return per unit of risk over the last 3 months. By inspecting Univec's technical indicators, you can evaluate if the expected return of 0.64% is justified by implied risk. Please review Univec's Coefficient Of Variation of 2879.87, semi deviation of 6.77, and Risk Adjusted Performance of 0.0371 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Univec holds a performance score of 6. The entity has a beta of 0.54, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Univec's returns are expected to increase less than the market. However, during the bear market, the loss of holding Univec is expected to be smaller as well. Please check Univec's treynor ratio, as well as the relationship between the semi variance and day median price , to make a quick decision on whether Univec's existing price patterns will revert.

Auto-correlation

    
  0.05  

Virtually no predictability

Univec Inc has virtually no predictability. Overlapping area represents the amount of predictability between Univec time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Univec Inc price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Univec price fluctuation can be explain by its past prices.
Correlation Coefficient0.05
Spearman Rank Test-0.2
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Univec Inc reported net income of (1.18 Million). This is 100.35% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.21% higher than that of the company.

Univec Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Univec's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Univec could also be used in its relative valuation, which is a method of valuing Univec by comparing valuation metrics of similar companies.
Univec is currently under evaluation in net income category among its peers.

Univec Fundamentals

About Univec Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Univec Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Univec using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Univec Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Univec Pink Sheet

Univec financial ratios help investors to determine whether Univec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Univec with respect to the benefits of owning Univec security.